Cytori, Lorem Vascular To Commercialize Cell-Based Therapies In Asia

21-11-2013 Asian Scientist MagazineComments (0)

Cytori TherapeuticsLorem VascularPharmaceutical

Lorem Vascular will pay up to $500 million in fees for a 30-year license to Cytori Cell Therapy for all indications, excepting alopecia and aesthetics, in the licensed territories in the form of revenue milestones. In addition, Lorem Vascular agrees to ...

Read more on Asian Scientist Magazine

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top